The quantitative determination of risedronate in urine by SPE-LC-MS-MS

Details for Australian Patent Application No. 2008222912 (hide)

Owner Sanofi-Aventis U.S. LLC

Inventors Shen, Liduo; Luo, Yongyi

Agent Watermark

Pub. Number AU-A-2008222912

PCT Pub. Number WO2008/109632

Priority 60/893,444 07.03.07 US

Filing date 5 March 2008

Wipo publication date 12 September 2008

International Classifications

G01N 33/52 (2006.01) Investigating or analysing materials by specific methods not covered by groups -

B01D 15/36 (2006.01) Separating processes involving the treatment of liquids with solid sorbents

G01N 30/00 (2006.01) Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography

Event Publications

1 October 2009 PCT application entered the National Phase

  PCT publication WO2008/109632 Priority application(s): WO2008/109632

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008222926-Amelioration of cellular stress response

2008222910-Syringe assembly having disabling mechanism with tamper resistance features